Related Experiment Video
Updated: Oct 1, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic Predisposition to Coronavirus Disease 2019 in Relation to Ten Cardiovascular Conditions: A Two-Sample
Min Jia1, He-Jia Chen1, Ling-Mei Jia1
1Cardiovascular Medicine Department, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Insights
This study used Mendelian randomization to investigate the link between COVID-19 and cardiovascular disease. Findings suggest COVID-19 infection increases the risk of major coronary heart disease events and heart failure.
Area of Science:
- Genetics
- Epidemiology
- Cardiology
Background:
- Long-term health effects of COVID-19 are not well understood.
- Cardiovascular disease is a significant global health concern.
- Investigating the relationship between infectious diseases and chronic conditions is crucial.
Purpose of the Study:
- To determine the causal association between COVID-19 and ten cardiovascular conditions using a Mendelian randomization design.
- To provide robust evidence on the cardiovascular risks associated with COVID-19 infection.
Main Methods:
- Utilized single-nucleotide polymorphisms (SNPs) associated with COVID-19 as instrumental variables.
- Employed the inverse-variance weighted (IVW) method for primary analysis.
- Conducted complementary analyses using weighted median and MR-Egger approaches to ensure robustness and assess pleiotropy.
Main Results:
- Genetically predicted COVID-19 showed a suggestive association with increased risk of major coronary heart disease events (OR 1.081, P=0.045).
- A similar suggestive association was observed for heart failure (OR 1.049, P=0.045).
- No evidence of directional pleiotropic effects was found, supporting the validity of the causal inference.
Conclusions:
- COVID-19 infection is causally linked to an elevated risk of cardiovascular disease.
- The findings highlight specific risks for major coronary heart disease events and heart failure post-COVID-19.
- This research provides direct evidence supporting the need for cardiovascular monitoring in COVID-19 patients.
Background:
The long-term health consequences of coronavirus disease 2019 (COVID-19) remain largely unclear. This study aimed to apply the Mendelian randomization (MR) design to estimate the causal associations between COVID-19 and ten cardiovascular conditions.
Methods:
Single-nucleotide polymorphisms (SNPs) associated with COVID-19 were used as instrumental variables to estimate the causal effect of COVID-19 on ten cardiovascular conditions. The random-effects inverse-variance weighted (IVW) method was conducted for the main analyses with a complementary analysis of the weighted median and MR-Egger approaches.
Results:
In the IVW analysis, genetically predicted COVID-19 was suggestively associated with major coronary heart disease events (OR 1.081; 95% CI 1.007-1.16; P = 0.045) and heart failure (OR 1.049; 95% CI 1.001-1.1; P = 0.045) with similar estimates in weighted median regressions. No directional pleiotropic effects were observed in both funnel plots and MR-Egger intercepts.
Conclusions:
Our findings provide direct evidence that patients infected with COVID-19 are causally associated with increased risk of cardiovascular disease, especially for major coronary heart disease events and heart failure.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Coronary Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Bias in Epidemiological Studies

